Physician profile
James A Williams
NPI 1528040854
$7,513.78
in general payments reported to CMS, 2019-2025
73 companies · $1,499 in 2025
The $1,499 reported for 2025 was more than what 75% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,361 · 2020: $351 · 2021: $173 · 2022: $1,043 · 2023: $1,526 · 2024: $1,561 · 2025: $1,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,585.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $837.75 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $804.06 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Lilly USA, LLC | $427.74 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Myriad Genetic Laboratories, INC. | $385.35 | 2020-2023 | Myrisk, Precisetumor |
| Astrazeneca Pharmaceuticals LP | $380.37 | 2019-2025 | Enhertu, Tagrisso, Calquence |
| Heron Therapeutics, INC. | $275.32 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $258.27 | 2019-2025 | Ninlaro, Fruzaqla |
| Daiichi Sankyo INC. | $252.47 | 2019-2025 | Injectafer, Enhertu, Datroway |
| Genentech USA, INC. | $249.28 | 2019-2025 | Polivy, Lunsumio, Venclexta |
| Glaxosmithkline, LLC. | $218.99 | 2022-2025 | Jemperli, Zejula, Ojjaara |
| Janssen Biotech, INC. | $166.52 | 2019-2025 | Rybrevant, Balversa, Erleada |
| Abbvie INC. | $156.38 | 2019-2025 | |
| Pfizer INC. | $137.30 | 2020-2025 | |
| Adc Therapeutics America, INC. | $130.17 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $129.94 | 2019-2025 | Onivyde, Somatuline Depot |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $120.31 | 2023-2025 | Monjuvi, Zynyz, Pemazyre |
| Genmab U.S., INC. | $117.27 | 2023-2025 | Tivdak, Epkinly |
| Foundation Medicine, INC. | $114.67 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $96.12 | 2023-2025 | Libtayo |
| Genzyme Corporation | $95.02 | 2019-2025 | |
| Immunocore Limited | $94.58 | 2024-2025 | Kimmtrak |
| Clovis Oncology, INC. | $94.53 | 2019 | |
| Eisai INC. | $93.98 | 2019-2024 | |
| Emd Serono, INC. | $88.48 | 2023-2025 | Tepmetko |
| Flower Orthopedics Coporation | $87.83 | 2021 | |
| Taiho Oncology, INC. | $85.15 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.50 | 2024-2025 | Gilotrif |
| Kyowa Kirin, INC. | $79.61 | 2019-2024 | Poteligeo |
| Bayer Healthcare Pharmaceuticals INC. | $75.94 | 2019-2023 | |
| Celgene Corporation | $74.03 | 2019-2023 | Reblozyl |
| Seagen INC. | $64.25 | 2019-2023 | Adcetris |
| Exelixis INC. | $62.28 | 2023-2024 | Cabometyx |
| Pharmaessentia USA Corporation | $52.52 | 2024 | Besremi |
| Aveo Pharmaceuticals, INC. | $52.24 | 2024-2025 | |
| Sobi, INC | $51.94 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $50.73 | 2022-2023 | |
| Servier Pharmaceuticals LLC | $47.46 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $47.03 | 2020-2023 | Xarelto |
| Stemline Therapeutics INC. | $46.98 | 2025 | Orserdu |
| Gilead Sciences, INC. | $44.73 | 2019-2023 | Trodelvy |
| Astellas Pharma US INC | $42.34 | 2019 | |
| Deciphera Pharmaceuticals INC. | $40.84 | 2023 | Qinlock |
| Sumitomo Pharma America, INC. | $39.08 | 2024 | Orgovyx |
| Springworks Therapeutics, INC. | $35.55 | 2024-2025 | Ogsiveo |
| Amgen INC. | $33.19 | 2019 | |
| Beigene USA, INC. | $32.54 | 2023 | Brukinsa |
| Coopersurgical, INC. | $32.03 | 2019-2025 | Ally II Ups |
| Mirati Therapeutics, INC. | $29.71 | 2023 | Krazati |
| Macrogenics, INC. | $28.75 | 2023 | |
| Karyopharm Therapeutics INC. | $27.96 | 2023-2024 | Xpovio |
| Cti Biopharma Corp. | $27.39 | 2022-2023 | Vonjo |
| Secura Bio, INC. | $27.30 | 2020 | |
| Array Biopharma INC | $26.93 | 2024 | Braftovi, Mektovi, Xalkori |
| Genentech, INC. | $25.79 | 2024 | Lunsumio, Columvi |
| Ethicon US, LLC | $25.06 | 2024 | Surgicel Nu-Knit, Stratafix, Dermabond Prineo |
| Spectrum Pharmaceuticals INC. | $24.34 | 2023 | Rolvedon |
| Alexion Pharmaceuticals, INC. | $23.21 | 2023 | Ultomiris |
| Novocure INC. | $22.74 | 2025 | Optune Lua (Novottf-200t) |
| Blueprint Medicines Corporation | $22.59 | 2025 | Ayvakit |
| Dova Pharmaceuticals | $22.54 | 2019 | |
| Aurobindo Pharma USA, INC. | $21.50 | 2019 | |
| Verastem, INC. | $19.77 | 2025 | Avmapki Fakzynja Co-Pack |
| Eagle Pharmaceuticals, INC. | $17.85 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $16.16 | 2023 | Eliquis |
| Morphosys, US INC. | $15.23 | 2022 | |
| Pharmacosmos Therapeutics INC. | $14.79 | 2023 | Monoferric |
| Tesaro, INC. | $14.48 | 2019 | |
| Coherus Oncology, INC. | $14.31 | 2025 | Loqtorzi |
| Puma Biotechnology, INC. | $13.08 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $12.60 | 2019 | |
| Mylan Institutional INC. | $12.57 | 2020 | |
| Agios Pharmaceuticals, INC. | $11.53 | 2019 | |
| Rigel Pharmaceuticals, INC. | $10.94 | 2023 | Rezlidhia, Tavalisse |
Drugs and devices associated with these payments
Keytruda $506Kisqali $321Jaypirca $309Verzenio $309Piqray $162Jemperli $132Zejula $132Injectafer $130Myrisk $119Lunsumio $110Elahere $108Lynparza $105Polivy $104Tivdak $100Libtayo $96.12Retevmo $95.98Kimmtrak $94.58Enhertu $91.20Monjuvi $85.26Welireg $83.57Rybrevant $82.37Lenvima $77.01Columvi $72.98Adcetris $69.68Lonsurf $63.35Inqovi $63.35Venclexta $62.99Cabometyx $62.28Fabhalta $61.26Poteligeo $55.17Besremi $52.52Fotivda $52.24Doptelet $51.94Elrexfio $51.82Tecentriq $47.26Orserdu $46.98Zynlonta $46.56Zynyz $45.47Onivyde $44.40Ayvakit $41.80Tagrisso $41.10Qinlock $40.84Ibrance $39.83Pemazyre $39.79Orgovyx $39.08Tepmetko $36.86Ogsiveo $35.55Jakafi $35.05Tukysa $34.25Calquence $33.98Sarclisa $32.85Brukinsa $32.54Promacta $31.94Ninlaro $31.85Precisetumor $31.03Gilotrif $30.48Lutathera $30.47Krazati $29.71Margenza $28.75Xpovio $27.96Zepzelca $27.35Braftovi $26.93Mektovi $26.93Datroway $26.63Stratafix $25.06Vistaseal $25.06Dermabond Prineo $25.06Surgicel Nu-Knit $25.06Voranigo $24.48Rolvedon $24.34Ultomiris $23.21Tibsovo $22.98Somatuline Depot $22.83Optune Lua (Novottf-200t) $22.74Padcev $20.69Inlyta $20.69Ojjaara $20.26Avmapki Fakzynja Co-Pack $19.77Erleada $19.45Akeega $19.45Balversa $19.45Comirnaty $18.72Trodelvy $18.61Ally II Ups $18.24Pemfexy $17.85Fruzaqla $17.67Niktimvo $17.64Epkinly $17.27Reblozyl $16.79Xarelto $16.68Eliquis $16.16Blenrep $16.12Bosulif $15.32Perjeta $14.88Alecensa $14.88Monoferric $14.79Loqtorzi $14.31Xalkori $13.79Lorbrena $13.79Vonjo $13.59
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.